Costs To Manage Pain Will Go Up Under Obamacare

Global Pain Management Devices Market Report 2013-2018

As a result, the health care delivery of these services has saved billions in health care costs while providing safer, more accessible care for those who suffer from chronic and severe pain. With these extreme cuts nearly 60 percent in some cases — physicians will no longer be able to provide these services in non-hospital settings, as they will cost far more to provide than Medicare will pay. In a few short weeks, it will cost more to have these procedures, epidural injections, done in a hospital than in the physician’s office suite — over 7 times the cost. As a result, thousands of elderly Floridians will be forced to suffer without the treatment they so desperately need. The American Society of Interventional Pain Physicians, estimates that 40 percent of these highly specialized physicians will likely close up shop and Medicare expenses will increase by nearly $200 million as a result of increased hospitalizations. These dollar figures of course do not take into account the immeasurable amount of human suffering that will result as well. With decreased access to point-of-pain treatment centers, highly addictive pain drugs like Oxycontin , hydrocodone or other narcotic pain pills may be the only option for Medicare patients with chronic and severe pain. During the last decade, Florida lawmakers wisely closed the door on unscrupulous providers who gave out pain medications like they were working in candy dispensaries. Thankfully, today these highly controlled medications are less likely to be abused in Florida. As a result of the work of dedicated lawmakers and our state’s Attorney General, Floridians are safer, dangerous drug sales are down, and our state is saving millions in unnecessary costs. But with the federal government’s unwise proposal to slash payments for highly specialized interventional pain treatment, chronic pain patients will be forced to seek relief from the only available sources they can find. I shudder to think of the results.
For the original version including any supplementary images or video, visit,0,6865269.story

Dennis Lanane: Triad workshop to focus on pain management

Unfortunately the recipient of this year’s award, Cindy Carson, was not able to attend because she was recuperating from knee surgery. Scott volunteered to take the award to her and she was completely surprised. Cindy has been a longtime supporter of Triad dating back to when she was a reporter for The Herald Bulletin. Cindy wrote several feature stories about Triad. She did one story on Bob Highsmith, our Senior Link coordinator, with several pictures. He was calling about 300 people a month to check on their health chiropractor bayview and well-being. Several months later Triad had a big picnic for our members and people who were signed up for the Senior Link program. Several of the ladies that were at the meeting told Bob they had cut his picture out of the newspaper and taped it to their refrigerator so they could see what he looked like when he called. Cindy agreed a bayview chiropractic couple of months ago to become our first Triad Senior Link coordinator since Bob has passed away. We are hoping to get many more seniors signed up with the Senior Link program to get monthly welfare checks.
For the original version including any supplementary images or video, visit

WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact . SOURCE Research and Markets DUBLIN, December 27, 2013 /PRNewswire/ — (Logo: ) The global pain management therapeutics market is expected to witness a decline during the forecast period (2012 to 2018) due to patent expirations of the key revenue generating drugs such as Cymbalta (duloxetine) of Eli Lilly & Co. and Lyrica (pregabalin) of Pfizer, Inc. This report studies the global market for pain management therapeutics from http://bayviewwellness.COM three perspectives – therapeutic classes of drugs, indications and geography. Each of these segments is further classified into sub-segments; therapeutic classes include anticonvulsants, antidepressants, anesthetics, NSAIDs, opioids, anti-migraine agents and other non-narcotic analgesics. The various pain management indications studied in this report include neuropathic pain, fibromyalgia, arthritic pain, chronic back pain, migraine, post-operative pain and cancer pain. Market sizes and forecasts for the period 2010 – 2018 have been provided for each of the segments and sub-segments in terms of USD million, considering 2011 as the base year. The % compound annual growth rate (CAGR) for each market segment for the forecast period (2012 to 2018) has been provided along with market size estimations.
For the original version including any supplementary images or video, visit


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s